Big breakthrough in medical treatment: Korean scientists find undo button that turns tumour cells into normal ones

Researchers in Korea have discovered a way to reverse cancer and change tumour cells back to normal. A groundbreaking development in cancer treatment has been made by researchers at Korea Advanced Institute of Science and Technology (KAIST), who have created a technology that changes colon cancer cells into healthy cells without killing them.

The Department of Bio and Brain Engineering's Professor Kwang-Hyun Cho is spearheading this novel approach, which marks a substantial shift from conventional cancer treatments that depend on eradicating cancer cells, which frequently result in serious side effects and recurrence risks.

The ability of cancer cells to transform back into healthy cells is a remarkable phenomenon. This study demonstrates that it is possible to systematically induce such reversion, Cho said.


ALSO READ
South Korean Plane Crash Cause: What went wrong with Jeju Air killing 179?

Reevaluating the pathogenesis of cancer cells

The researchers explain in the paper's introduction how studies on hepatocellular carcinoma, breast cancer, and acute myeloid leukaemia have demonstrated that this reversal can be accomplished by promoting tumour cells to differentiate or trans-differentiate.

The goal of traditional cancer treatments is to destroy cancer cells. Although this approach is often successful, it has two major drawbacks: the possibility that cancer cells will become resistant and recur, as well as the collateral harm to healthy cells that could cause crippling side effects.

The KAIST team took a radically different approach by targeting the root causes of cancer development. They created a digital twin of the gene network involved in the differentiation trajectory of normal cells, allowing them to simulate and analyze the intricate gene interactions that regulate cell differentiation. Through simulations, the team pinpointed master molecular switches capable of steering cells from colon cancer back into a normal-like state.

The implications of this research are profound, as it could lead to the formulation of a new class of cancer treatments that could potentially minimize side effects and reduce the likelihood of recurrence. This innovative approach marks a paradigm shift in cancer treatment, providing a roadmap for safer and potentially more effective therapies.

FAQs

How do Korean researchers convert cancer cells to normal cells?
KAIST scientists used digital twin technology to simulate gene interactions in order to identify molecular switches that allow colon cancer cells to return to a normal state without killing them.

Why is this new cancer treatment important?
Unlike traditional therapies, this method reduces side effects and recurrence by transforming cancer cells into normal-like ones, providing a safer and potentially more effective treatment option.